Outlook Therapeutics Inc (NASDAQ:OTLK)

1.39
Delayed Data
As of Aug 14
 +0.05 / +3.73%
Today’s Change
0.50
Today|||52-Week Range
2.14
+135.59%
Year-to-Date
Outlook Therapeutics EPS beats by $0.07
Aug 14 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close1.34
Today’s open1.33
Day’s range1.33 - 1.49
Volume110,195
Average volume (3 months)2,422,584
Market cap$160.1M
Data as of 3:59pm ET, 08/14/2020

Growth & Valuation

Earnings growth (last year)+79.65%
Earnings growth (this year)+48.55%
Earnings growth (next 5 years)--
Revenue growth (last year)+163.84%
P/E ratioNM
Price/Sales3.33
Price/Book--

Competitors

 Today’s
change
Today’s
% change
JNCEJounce Therapeutics ...-0.15-3.11%
PIRSPieris Pharmaceutica...-0.07-2.25%
EQEquillium Inc-1.57-17.80%
NCNANuCana PLC+0.15+2.85%
Data as of 4:53pm ET, 08/14/2020

Financials

Last reporting dateAugust 14, 2020
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$8.1M
Annual profit (last year)-$34.6M
Net profit margin-424.56%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
South Brunswick, New Jersey

Forecasts